T. Schenker

948 total citations
22 papers, 764 citations indexed

About

T. Schenker is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, T. Schenker has authored 22 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in T. Schenker's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Lung Cancer Research Studies (3 papers). T. Schenker is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Lung Cancer Research Studies (3 papers). T. Schenker collaborates with scholars based in Switzerland, United Kingdom and Canada. T. Schenker's co-authors include Beat Trüeb, Uwe Zangemeister‐Wittke, R. Stahel, Rolf A. Stahel, Walter R. Gilks, Robert Waibel, Benedikt M. Kessler, Silvio Calderara, Antonio Baici and Daniele Belluoccio and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Journal of Neurochemistry.

In The Last Decade

T. Schenker

21 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Schenker Switzerland 12 317 249 156 131 110 22 764
Shengyu Yang United States 13 714 2.3× 471 1.9× 196 1.3× 94 0.7× 196 1.8× 18 1.2k
Young-Sun Kang South Korea 12 700 2.2× 115 0.5× 67 0.4× 46 0.4× 55 0.5× 13 987
Chunqing Cai China 14 486 1.5× 132 0.5× 82 0.5× 56 0.4× 50 0.5× 23 771
Laura L. Wootton United Kingdom 10 391 1.2× 83 0.3× 62 0.4× 22 0.2× 118 1.1× 10 602
Wan‐Chen Huang Taiwan 16 472 1.5× 89 0.4× 99 0.6× 56 0.4× 70 0.6× 37 773
Taiguang Jin United States 11 494 1.6× 61 0.2× 156 1.0× 76 0.6× 38 0.3× 13 646
K. A. Barzen United States 11 527 1.7× 37 0.1× 112 0.7× 46 0.4× 105 1.0× 15 722
Toshiyuki Minami Japan 12 211 0.7× 121 0.5× 188 1.2× 188 1.4× 42 0.4× 57 653
Christie‐Ann McCarl United States 7 239 0.8× 399 1.6× 51 0.3× 55 0.4× 138 1.3× 9 693
Hélène Pelczar France 10 299 0.9× 58 0.2× 83 0.5× 47 0.4× 60 0.5× 21 511

Countries citing papers authored by T. Schenker

Since Specialization
Citations

This map shows the geographic impact of T. Schenker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Schenker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Schenker more than expected).

Fields of papers citing papers by T. Schenker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Schenker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Schenker. The network helps show where T. Schenker may publish in the future.

Co-authorship network of co-authors of T. Schenker

This figure shows the co-authorship network connecting the top 25 collaborators of T. Schenker. A scholar is included among the top collaborators of T. Schenker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Schenker. T. Schenker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tatari, Nazanin, Andreas Zingg, Viviane J. Tschan, et al.. (2023). P06.15.B IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY. Neuro-Oncology. 25(Supplement_2). ii49–ii49. 1 indexed citations
2.
Schenker, T. & Beat Trüeb. (2000). BSPRY, a novel protein of the Ro-Ret family. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1493(1-2). 255–258. 6 indexed citations
3.
Schenker, T., et al.. (1999). An Ankyrin-like Protein with Transmembrane Domains Is Specifically Lost after Oncogenic Transformation of Human Fibroblasts. Journal of Biological Chemistry. 274(11). 7325–7333. 259 indexed citations
4.
Schenker, T. & Beat Trüeb. (1998). Down-Regulated Proteins of Mesenchymal Tumor Cells. Experimental Cell Research. 239(1). 161–168. 39 indexed citations
5.
Belluoccio, Daniele, T. Schenker, Antonio Baici, & Beat Trüeb. (1998). Characterization of Human Matrilin-3 (MATN3). Genomics. 53(3). 391–394. 35 indexed citations
6.
Zangemeister‐Wittke, Uwe, et al.. (1998). Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines. British Journal of Cancer. 78(8). 1035–1042. 130 indexed citations
7.
Schenker, T. & Beat Trüeb. (1997). Assignment of the gene for a developmentally regulated GTP-binding protein (DRG2) to human chromosome bands 17p13→p12 by in situ hybridization. Cytogenetic and Genome Research. 79(3-4). 274–275. 3 indexed citations
8.
Schenker, T. & Beat Trüeb. (1996). Tissue transglutaminase in mesenchymal tumour cells. APOPTOSIS. 1(2). 126–130. 4 indexed citations
9.
Stahel, Rolf A., et al.. (1994). Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis. International Journal of Cancer. 57(S8). 6–26. 95 indexed citations
10.
Gilks, Walter R., Rolf A. Stahel, Natalie Walker, & T. Schenker. (1994). Statistical analysis of data from the third international ialsc workshop on lung tumor and differentiation antigens. International Journal of Cancer. 57(S8). 2–5. 1 indexed citations
11.
Zangemeister‐Wittke, Uwe, et al.. (1994). Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer. British Journal of Cancer. 69(1). 32–39. 16 indexed citations
12.
Stahel, R., Walter R. Gilks, & T. Schenker. (1994). Antigens of Lung Cancer: Results of the Third International Workshop on Lung Tumor and Differentiation Antigens. JNCI Journal of the National Cancer Institute. 86(9). 669–672. 12 indexed citations
13.
Jackson, David G., T. Schenker, Robert Waibel, James Bell, & Rolf A. Stahel. (1994). Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. International Journal of Cancer. 57(S8). 110–115. 36 indexed citations
14.
Smith, Alan Р., Uwe Zangemeister‐Wittke, Robert Waibel, et al.. (1994). A comparison of67Cu- and131I-labelled forms of monoclonal antibodies SEN7 and SWA20 directed against small-cell lung cancer. International Journal of Cancer. 57(S8). 43–48. 15 indexed citations
15.
Weber, Erich, et al.. (1994). Immunological evidence for co-expression of cluster-5 and cluster-5A small cell lung cancer antigen on a single molecule. International Journal of Cancer. 57(S8). 76–80. 2 indexed citations
16.
Schenker, T., et al.. (1994). A novel GTP-binding protein which is selectively repressed in SV40 transformed fibroblasts.. Journal of Biological Chemistry. 269(41). 25447–25453. 63 indexed citations
17.
Schumacher, Udo, et al.. (1993). Reactivity of Monoclonal Antibodies Directed against Lung Cancer Antigens with Human Lung, Breast and Colon Cancer Cell Lines. Disease Markers. 11(5-6). 225–237. 1 indexed citations
18.
Fontana, Alberto, et al.. (1987). [Autoimmune hemolysis after Catergen ([+]-cyanidanol-3)].. PubMed. 117(46). 1824–7. 1 indexed citations
19.
Höger, P., et al.. (1985). [Acanthocytosis in chronic septic granulomatosis: the McLeod syndrome].. PubMed. 133(5). 296–9. 1 indexed citations
20.
Schoenle, Ε., Werner Schmid, Albert Schinzel, et al.. (1983). 46,XX/46,XY chimerism in a phenotypically normal man. Human Genetics. 64(1). 86–89. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengyu Yang Breakdown of academic impact, for papers by Young-Sun Kang Breakdown of academic impact, for papers by Chunqing Cai Breakdown of academic impact, for papers by Laura L. Wootton Breakdown of academic impact, for papers by Wan‐Chen Huang Breakdown of academic impact, for papers by Taiguang Jin Breakdown of academic impact, for papers by K. A. Barzen Breakdown of academic impact, for papers by Toshiyuki Minami Breakdown of academic impact, for papers by Christie‐Ann McCarl Breakdown of academic impact, for papers by Hélène Pelczar
Rankless by CCL
2026